Evoke Pharma, Inc.
Symbol: EVOK (NASDAQ)
4.93
▲ (2.28%) 0.110
Company Description:
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Key Stats
- Today's Open: $4.82
- Today's High: $4.975
- Today's Low: $4.78
- Today's Volume: 3.53K
- Yesterday Close: $4.82
- Yesterday High: $5.16
- Yesterday Low: $4.8
- Yesterday Volume: 25.83K
- Last Min Volume: 200
- Last Min High: $4.93
- Last Min Low: $4.93
- Last Min VWAP: $4.93
Company Profile
- Name: Evoke Pharma, Inc.
- Website: https://www.evokepharma.com
- Listed Date: 2013-09-25
- Location: SOLANA BEACH, CA
- Market Status: Active
- CIK Number: 0001403708
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $7.51M
- Round Lot: 100
- Outstanding Shares: 1.56M
- Asset Type: CS
RECENT FILINGS FOR EVOK
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | SCHEDULE 13G | View |
| 2025-08-14 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-09 | 8-K | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-10 | ARS | View |
| 2025-04-10 | DEFA14A | View |
| 2025-04-10 | DEF 14A | View |
| 2025-03-24 | SCHEDULE 13G/A | View |
Latest News on EVOK